Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 510,173 | 426,454 | 258,215 | 154,080 | 80,943 |
| Cost of Goods | 217,408 | 206,901 | 169,273 | 118,815 | 79,770 |
| Gross Profit | 292,765 | 219,553 | 88,942 | 35,265 | 1,173 |
| Operating Expenses | 101,730 | 81,471 | 67,583 | 75,445 | 60,317 |
| Operating Income | 191,443 | 138,983 | 21,632 | -39,365 | -58,374 |
| Interest Expense | 7,110 | 13,930 | 25,027 | 19,279 | 13,057 |
| Other Income | -1,677 | 661 | -24,844 | -7,260 | -217 |
| Pre-tax Income | 182,656 | 125,714 | -28,239 | -65,904 | -71,648 |
| Income Tax | 35,726 | -71,959 | 0 | N/A | N/A |
| Net Income Continuous | 146,930 | 197,673 | -28,239 | -65,904 | -71,648 |
| Net Income | $146,930 | $197,673 | $-28,239 | $-65,904 | $-71,648 |
| EPS Basic Total Ops | 0.62 | 0.85 | -0.13 | -0.33 | -0.51 |
| EPS Basic Continuous Ops | 0.62 | 0.85 | -0.13 | -0.33 | -0.51 |
| EPS Diluted Total Ops | 0.60 | 0.81 | -0.13 | -0.33 | -0.51 |
| EPS Diluted Continuous Ops | 0.60 | 0.81 | -0.13 | -0.33 | -0.51 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.49 | 0.00 | -0.30 | -0.51 |
| EBITDA(a) | $200,113 | $147,836 | $32,415 | $-29,993 | $-51,124 |